1380697-48-2

Upstream product

• 81245-39-8 2-iodo-1-(methyloxy)-3-{[(methyloxy)methyl]oxy}benzene 
• 57234-28-3 1-methoxy-3-(methoxymethoxy)benzene 
• 150-19-6 O-methylresorcine 
• 121980-50-5 2-iodo-3-(methyloxy)phenol 
• 563-47-3 3-Chloro-2-methylpropene 

Downstream Products

• 1380696-16-1 (5R)-3-{4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]phenyl}-5-methyl-2,4-imidazolidinedione 
• 1380697-56-2 N₁-{4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]phenyl}-D-alaninamide 
• 1380697-55-1 1,1-dimethylethyl [(1R)-2-({4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]phenyl}amino)-1-methyl-2-oxoethyl]carbamate 
• 1380697-54-0 4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]aniline 
• 1380697-53-9 3,3-dimethyl-4-[(4-nitrophenyl)oxy]-2,3-dihydro-1-benzofuran 
• 1232362-02-5 3,3-dimethyl-2,3-dihydro-1-benzofuran-4-ol 

Relevant academic research and scientific papers

NOVEL COMPOUNDS

The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.